Wakayama, Japan

Satoshi Miyamoto

This inventor holds 1 USPTO granted patent. Top assignee: Fuji Yakuhin Kogyo Kabushiki Kaisha. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Miyamoto. Retrieved from https://idiyas.com/inventor/satoshi-miyamoto-8n658ny2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Satoshi Miyamoto: Innovator in Collagen Peptide Detection

Introduction

Satoshi Miyamoto is a notable inventor based in Wakayama, Japan. He has made significant contributions to the field of biomedical diagnostics, particularly in the detection of collagen peptides.

Latest Patents

Miyamoto holds a patent for a method for determining human collagen peptides by way of enzyme immunoassay. This innovative technique utilizes a sandwich method involving both monoclonal and polyclonal antibodies specific to human type III, IV, and VI collagen peptides. The method is characterized by its ability to use a monoclonal antibody as a coating on a solid phase and/or as an enzyme-labeled antibody. This approach allows for the analysis of smaller sample sizes while providing precise results, making it particularly useful for diagnosing hepatic diseases.

Career Highlights

Miyamoto is associated with Fuji Yakuhin Kogyo Kabushiki Kaisha, a company that focuses on pharmaceutical and diagnostic products. His work has been instrumental in advancing diagnostic techniques in the medical field.

Collaborations

Miyamoto has collaborated with notable colleagues, including Akira Oshima and Kazushi Iwata, contributing to the development of innovative diagnostic methods.

Conclusion

Satoshi Miyamoto's contributions to the field of collagen peptide detection exemplify the impact of innovative thinking in medical diagnostics. His patented method represents a significant advancement that can enhance the accuracy of disease diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…